Zacks Investment Research upgraded shares of Hanger (OTCMKTS:HNGR) from a sell rating to a hold rating in a research report report published on Wednesday.
According to Zacks, “Hanger, Inc. delivers orthotic and prosthetic patient care, and distributes O&P products and rehabilitative solutions. The company’s products & services segment provides Hanger distributes branded and private label O&P devices, products and components and provides rehabilitative solutions. Hanger Inc., formerly known as Hanger Orthoped, is based in AUSTIN, Texas. “
HNGR has been the subject of a number of other research reports. TheStreet cut shares of Hanger from a c rating to a d rating in a research note on Wednesday, October 31st. ValuEngine cut shares of Hanger from a buy rating to a hold rating in a research note on Monday, August 13th.
OTCMKTS:HNGR opened at $20.03 on Wednesday. Hanger has a 1 year low of $11.56 and a 1 year high of $24.50.
Hanger (OTCMKTS:HNGR) last posted its earnings results on Thursday, November 8th. The healthcare company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01. The firm had revenue of $262.95 million during the quarter, compared to the consensus estimate of $260.07 million.
Large investors have recently bought and sold shares of the company. First Manhattan Co. acquired a new stake in shares of Hanger in the third quarter valued at approximately $1,345,000. Deltec Asset Management LLC acquired a new stake in shares of Hanger in the third quarter valued at approximately $1,510,000. FMR LLC acquired a new stake in shares of Hanger in the third quarter valued at approximately $64,735,000. Trexquant Investment LP acquired a new stake in shares of Hanger in the third quarter valued at approximately $389,000. Finally, Wells Fargo & Company MN acquired a new stake in shares of Hanger in the third quarter valued at approximately $17,259,000. Institutional investors own 3.61% of the company’s stock.
Hanger, Inc provides orthotic and prosthetic (O&P) services; and distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings in the United States. It operates through two segments, Patient Care and Products & Services.
Featured Story: What is Compound Annual Growth Rate (CAGR)?
Get a free copy of the Zacks research report on Hanger (HNGR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Hanger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hanger and related companies with MarketBeat.com's FREE daily email newsletter.